Skip to content

Comparison of efficacy of anitibitic befor and after C/S to prevent post_cesarean infection

Comparison of efficacy of prophylactic antibiotic prescribing before cesarean section and antibiotic administration after cord clamping on prevention of post-cesarean infection

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190526043710N1
Enrollment
180
Registered
2019-08-05
Start date
2019-06-14
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of efficacy of antibiotic prescribing before and after cesarean section.

Interventions

Intervention 1: Intervention group: 90 pregnant mothers eligible for inclusion in the study will be prescribed antibiotics (routinely: single dose Cefazolin 1 g in subjects weighing less than 80 kg -

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women who undergo C/S due to midwifery indications or other reasons Providing informed consent

Exclusion criteria

Exclusion criteria: Having underlying dieases (DM, liver dieases, kidney dieases, suppressd immune sys) The presence of chorioamnionitis criteria (loshia, tenderness, fever) Fever (oral temperature above 38 degrees) Rupture of memberans more than 24 hours Immunosuppressive drugs use (corticosteroids and etc) Use of antibiotics 24 hours before cesarean section

Design outcomes

Primary

MeasureTime frame
Incidence of post Cesarean infection. Timepoint: During the Hospitalization and 10 or 14 days after cesarean section. Method of measurement: Physical examination and judgment.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Shahbazzadeh

Sabzevar University of Medical Sciences

shahbazzadeZ90@medsab.ac.ir+98 21 7773 4246

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026